Study of Copanlisib and Ketogenic Diet

NCT04750941 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Enrollment challenges

Conditions

Follicular Lymphoma
Endometrial Cancer

Interventions

DRUG: Copanlisib
OTHER: Ketogenic Diet

Sponsor

Columbia University

Collaborators

[object Object]